Syncom Formulations (India) informs about disclosure

26 Feb 2024 Evaluate
Syncom Formulations (India) has informed that both the Stock Exchanges, BSE and NSE has imposed fines under regulation 21(2) of SEBI (LODR), 2015 for Non Compliance with the constitution of the Risk Management Committee by the Board of Directors of the Company for the quarter ended 31st December, 2023 for 92 days @ 2,000 per day plus GST, resulting the total penalty to Rs 1,84,00 plus GST 33,120 total Rs. 2,17,120by both the stock exchanges, vide SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023 on the company which is required to paid within 15 days from the date of the Letter/notice/mail received from both the exchanges. The Company is examining the direction and will take appropriate action and remains committed to ensure optimum compliances of all applicable laws. The details as required under SEBI Listing Regulations read with Circular no. SEBI/HO/ CFD/ CFDPoD-1/P-CIR//2023/123 dated July 13, 2023 are enclosed as Annexure A.

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

14.65 -0.19 (-1.28%)
17-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.10
Dr. Reddys Lab 1272.00
Cipla 1496.95
Zydus Lifesciences 918.35
Lupin 2113.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×